Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449637) titled 'Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma' on Feb. 27.

Study Type: Observational

Primary Sponsor: Sohag University

Condition: BCLC Stage B Hepatocellular Carcinoma

Recruitment Status: Not recruiting

Date of First Enrollment: March 2026

Target Sample Size: 200

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07449637

Disclaimer: Curated by HT Syndication....